International Congress Munich 2014


Ceremony for the ERS Idiopathic Pulmonary Fibrosis Research Award 2014 - Hot Topic: "Understanding and treating idiopathic pulmonary fibrosis (IPF) in the 21st century"

Hot topics
Chairs: G. Raghu (Seattle, United States of America), V. Poletti (Forli, Italy)
Aims: This session will provide insights into recent discoveries regarding the role of genetic predisposition in IPF and the pathophysiology of IPF. The audience will be updated on the results of recent clinical treatment trials that are going to change how patients with IPF are managed.
How to treat IPF: lessons from the NIH-IPF-Net treatment trials
H. R. Collard (San Francisco, United States of America)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Recent clinical treatment trials in IPF that focus on pirfenidone and nintedanib
L. Richeldi (Southampton, United Kingdom)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Managing IPF: connecting the dots
J. Behr (Munich, Germany)
Slide presentation
Slide presentation